BioCatalystWatch
KNSAWorkspace / KNSA / OverviewCompany library
Kiniksa Pharmaceuticals International, plc logo

Kiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals International, plc (KNSA)

Website

Price
Market cap
Next catalystExpected 2H 2027KPL-387 — PASTORALE Phase 2/3 · Phase 3 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

KPL-1161

IL-1R1

PreINDP2P3FilingApproved
Upcoming / outlook

KPL-387

IL-1R1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

KPL-1161

IL-1R1

PreINDP2P3FilingApproved
Upcoming / outlook

KPL-387

IL-1R1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

IL-1α × IL-1β

abiprubart (KPL-404)

CD40

PreINDP1P2P3FilingApproved
KPL-387

IL-1R1

PreINDP1P2P3FilingApproved

Partner / License out

OSMRβ

PreINDP1P2P3FilingApproved

OSMRβ

PreINDP1P2P3FilingApproved

Approved / commercial

History / paused

abiprubart (KPL-404)

CD40

PreINDP1P2P3FilingApproved

GM-CSFRα

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Shares outstanding

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

KNSA PR & News

PR & News

KNSA SEC archive